<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890641</url>
  </required_header>
  <id_info>
    <org_study_id>GDR_2015_15</org_study_id>
    <nct_id>NCT02890641</nct_id>
  </id_info>
  <brief_title>Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies</brief_title>
  <acronym>GENEPHY</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      Genetic abnormalities in focal epilepsies are well known. A novel gene (DEPDC5) was
      identified, associated with various genotypes of epilepsies. Recently, DEPDC5 mutations were
      identified also inside focal cortical dysplasias. This could suggest that a somatic mutation
      in DEPDC5 could be responsible for the cortical dysplasia. The study aims to identify various
      genetic mutations responsible for drug-resistant focal epilepsies due to Focal cortical
      dysplasia in children undergoing surgery for epilepsies due to focal cortical dysplasias in
      Rothschild Foundation, Paris. Patients and their parents will be recruited to identify
      genetic abnormalities both in lymphocytic and cortical DNA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>qualitative genetic analysis</measure>
    <time_frame>baseline</time_frame>
    <description>presence of genetic abnormalities, either in lymphocytic or in cortical DNA.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cortical Dysplasia-Focal Epilepsy Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with Focal Cortical Dysplasia</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>search for genetic abnormalities</intervention_name>
    <arm_group_label>Patients with Focal Cortical Dysplasia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        children with focal drug-resistant epilepsy, undergoing epilepsy surgery, and their
        parents.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children with focal drug-resistant epilepsy

          -  aged 6 month to 17 years old

          -  parents of these children

        Exclusion Criteria:

          -  refusal to participate in the study

          -  contraindication to anaesthesia, to MRI or to surgery

          -  no medical insurance coverage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Salomon, MD</last_name>
    <phone>+33 1 48 03 64 31</phone>
    <email>lsalomon@fo-rothschild.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschld</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Salomon, MD</last_name>
      <phone>+33 1 48 03 64 31</phone>
      <email>lsalomon@fo-rothschild.fr</email>
    </contact>
    <investigator>
      <last_name>Georg Dorfm√ºller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
    <mesh_term>Malformations of Cortical Development</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

